ERROR! No headcode.htm file found.

School of Medicine


Showing 1-100 of 110 Results

  • Karim Sallam, MD

    Karim Sallam, MD

    Assistant Professor of Medicine (Cardiovascular Medicine)

    Bio Karim Sallam, MD, is trained in Cardiovascular Medicine and Advanced Heart Failure.

  • Joshua Salomon

    Joshua Salomon

    Professor of Medicine (Primary Care and Outcomes Research) and Senior Fellow at the Freeman Spogli Institute for International Studies

    Bio Joshua Salomon is a Professor of Medicine and a core faculty member in the Center for Health Policy and the Center for Primary Care and Outcomes Research. His research focuses on public health policy and priority-setting, within three main substantive areas: (1) modeling patterns and trends in major causes of global mortality and disease burden; (2) evaluation of health interventions and policies; and (3) measurement and valuation of health outcomes.

    Dr. Salomon is an investigator on projects funded by the Centers for Disease Control and Prevention, National Institutes of Health and the Bill & Melinda Gates Foundation, relating to modeling of infectious and chronic diseases and associated intervention strategies; methods for economic evaluation of public health programs; measurement of the global burden of disease; and assessment of the potential impact and cost effectiveness of new health technologies.

    He is Director of the Prevention Policy Modeling Lab, which is a multi-institution research consortium that conducts health and economic modeling relating to infectious disease. Prior to joining the Stanford faculty, Dr. Salomon was Professor of Global Health at Harvard T.H. Chan School of Public Health.

    For more information on the Prevention Policy Modeling Lab visit ppml.stanford.edu.

  • Alexander Tarlochan Singh Sandhu

    Alexander Tarlochan Singh Sandhu

    Instructor, Medicine

    Bio Alex Sandhu, MD, MS is a cardiologist with a special interest in the care of patients with advanced heart failure. He graduated from the seven-year combined BA-MD program at Northwestern Feinberg School of Medicine. He completed an internal medicine residency at Stanford University, spending 16 weeks at Makerere Hospital in Uganda as part of the Global Health track. He subsequently obtained completed a Masters in Health Services Research at Stanford while acting as a fellow in health services research at the VA and Stanford's Center for Health Policy/Primary Care and Outcomes Research. He then completed fellowships in cardiology and advanced heart failure and transplant at Stanford before joining the faculty.

    He is an active heart failure researcher who focuses on health economics, the implementation of high-value care strategies, and comparative effectiveness. He is currently funded by a K23 career development award. In his free time, he enjoys playing soccer and teaching his son Kyle to play soccer (but not to head the ball).

  • Ashish Sarraju

    Ashish Sarraju

    Clinical Scholar, Medicine - Cardiovascular Medicine

    Bio Chief Fellow, Stanford Cardiovascular Medicine: 2020-present
    American Heart Association SFRN Postdoctoral Fellow, Heart Health Technology Center at the Stanford Center for Digital Health, 2020-present
    General Cardiology Fellow, Stanford Cardiovascular Medicine, 2018-present
    Chief Resident, Stanford Internal Medicine: 2017-2018
    Resident/Intern, Stanford Internal Medicine: 2014-2017

    Interests: Cardiovascular disease prevention; Health disparities; Digital health & health tech innovation to implementation; Clinical trials

  • Amelia Sattler

    Amelia Sattler

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Currently working on projects identifying effective use of actual patient encounters in undergraduate medical education. Specifically interested in the role of actual patient encounters in the training of shared decision making. Also interested in medical student empathy and physician wellness.

    Also working on many different projects in the realm of quality improvement and population health in the Division of Primary Care and Population Health.

  • John Scandling

    John Scandling

    Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests Tolerance induction in clinical kidney transplantation

  • Lidia Schapira

    Lidia Schapira

    Professor of Medicine (Oncology)

    Bio I am a medical oncologist focused on breast cancer and cancer survivorship. My career goal is to improve outcomes and experiences of patients and caregivers living with and beyond cancer, and my research and scholarship have contributed to understanding and meeting the needs of the growing population of cancer survivors. My editorial work for the Journal of Clinical Oncology has given me the opportunity to shape the discourse in oncology and as Editor-in-Chief of Cancer.Net I can bring high quality information about cancer to the lay public.

  • Erika Schillinger

    Erika Schillinger

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests My passion is clinical skills education: the patient's experience of health and healthcare, doctor-patient communication, professionalism and physical exam. I am focused on curriculum design and innovation, having helped develop the Continuity of Care Clerkship, the clinical skills curriculum in Practice of Medicine, the Family Medicine core clerkship, outpatient faculty development modules and the SHIELD course (Stanford Healthcare Innovations and Experiential Learning Directive).

  • Ingela Schnittger, MD

    Ingela Schnittger, MD

    Professor of Medicine (Cardiovascular)

    Current Research and Scholarly Interests My main research continues to be in the field of echocardiography. Several areas of research are currently being pursued.

  • Gary Schoolnik

    Gary Schoolnik

    Professor of Medicine (Infectious Diseases), Emeritus

    Current Research and Scholarly Interests Structure-function analysis of bacterial adhesion proteins and toxins; design and synthesis of synthetic antigens; immunobiology of human papillomaviruses

  • John S. Schroeder, MD

    John S. Schroeder, MD

    Professor (Clinical) of Medicine (Cardiovascular)

    Current Research and Scholarly Interests 1. Clinical Pharmocology of Cardiovascular Drugs
    (a) Calcium Channel Blockers
    (b) Agents for Heart Failure
    (c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers

    2. Cardiac Transplantation/Congestive Heart Failure

    3. Coronary Artery Spasm

  • Kevin Schulman

    Kevin Schulman

    Professor of Medicine (Hospital Medicine) and, by courtesy, of Operations, Information and Technology at the Graduate School of Business

    Bio Dr. Schulman was appointed as Professor of Medicine, Associate Chair of Business Development and Strategy in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Economics at Stanford?s Graduate School of Business in June, 2018. He is the Founding Faculty Director of the Master of Science in Clinical Informatics Management (MCiM) Program in the Stanford School of Medicine.

    Dr. Schulman?s research interests include organizational innovation in health care, health care policy and health economics. With over 300 original articles, 100 review articles/commentaries, and 40 case studies/book chapters, Kevin Schulman has had a broad impact on health policy (h-index = 69). His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Health Policy, Management and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Services Research.

    Prior to coming to Stanford, Dr. Schulman served as a Professor of Medicine at Duke University, directed the Health Sector Management Program at Duke?s Fuqua School of Business for a dozen years, created and directed the Duke University Master?s of Management in Clinical Informatics Program, and served as a Visiting Professor and Visiting Scholar at Harvard Business School.

    He is a co-founder of Bivarus (exit January, 2018), co-founder and Managing Member of Faculty Connection, LLC., and is a Board Member of Grid Therapeutics.

    He is an elected member of ASCI and AAP.

  • Jake Scott

    Jake Scott

    Clinical Assistant Professor, Medicine - Infectious Diseases

    Bio Dr. Jake Scott is a board-certified infectious diseases specialist. He provides general infectious diseases care in the inpatient and outpatient settings and his special interests include COVID-19, coccidiomycosis, multidrug-resistant organisms, HIV, and HIV pre-exposure prophylaxis. He works with patients from diverse backgrounds to provide compassionate, high-quality care aligned with their needs.

    Dr. Scott was born and raised in the Bay Area and was inspired to pursue a career in medicine after working as an HIV test counselor in San Francisco. He studied literature and creative writing in college and values the narrative aspect of medicine and the importance of drawing out the story behind the diagnosis.

    One of Dr. Scott?s passions is teaching. He regularly works with Stanford residents and students and has lectured on various infectious disease-related topics, such as COVID-19, fever of unknown origin, and the dangers of antibiotic overuse, especially as it contributes to the rising threat of multidrug-resistant infections. He is also committed to expanding awareness of infectious diseases outside of the hospital and university through public presentations in the community and media interviews.
    He is co-medical director of the Antibiotic Stewardship Program at Stanford Health Care ? ValleyCare in Pleasanton and member of the Infection Control Committee.

    In his spare time, Dr. Scott enjoys rock climbing, hiking, and spending time with his two young children.

  • Katharine Edwards

    Katharine Edwards

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Potential impact of brief behavioral interventions to improve adjustment, coping, medical adherence, and cardiovascular health among cardiac patients.

    Psychosocial challenges of patients with spontaneous coronary artery dissection (SCAD).

    Assessment and training in evidence-based psychological therapies.

  • Rebecca Seekamp, MD

    Rebecca Seekamp, MD

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Interested in complementary/alternative medicine, international health, international adoption medicine and providing full spectrum health care.

  • George Segall

    George Segall

    Professor of Radiology and, by courtesy, of Medicine (Cardiovascular)

    Current Research and Scholarly Interests Scintigraphic evaluation of coronary blood flow and myocardial function using single photon emission computed tomography (SPECT) and positron emission tomography (PET). Tumor imaging and characterization of pulmonary nodules with PET/CT.

  • Niraj Sehgal

    Niraj Sehgal

    Clinical Professor, Medicine

    Current Research and Scholarly Interests Quality Improvement & Patient Safety, Teamwork & Communication, Leadership
    Development, Organizational Culture & Change

  • Deborah Sellmeyer

    Deborah Sellmeyer

    Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    Bio Dr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.

  • Kinya Seo

    Kinya Seo

    Instructor, Medicine - Cardiovascular Medicine

    Bio Dr. Kinya Seo's primary research focus is on the determinants of myocardial function in the normal and diseased heart toward the goal for developing new therapies for heart failure. On a technical level, he possesses an unparalleled range of skills in molecular and cell biology, biomedical engineering, and model organisms research. He received his graduate training at the University of Tokyo, where he studied cardiac mechanics, electrophysiology, and computer simulation to investigate the mechanisms of arrhythmias induced by mechanical stimuli. After he received Ph.D., he moved to Baltimore to work in the laboratory of Dr. David Kass at Johns Hopkins University. He extended his skills and expertise toward the understanding of the pathogenesis of cardiac hypertrophy and heart failure with special focus on the influence of mechanical stimuli. After postdoctoral training, he went back to Japan working at Jichi Medical University as an assistant professor, where he developed intravital imaging technologies for cardiovascular events. These skills will allow him to extend his studies from cells to organs, and to human to perform translational study for heart diseases.

  • Robert W. Shafer

    Robert W. Shafer

    Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology

    Current Research and Scholarly Interests My group?s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.

  • Atulkumar T. Shah, MD

    Atulkumar T. Shah, MD

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    Bio Dr. Shah is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care?s Digestive Health program. He is a clinical associate professor of medicine in the division of Gastroenterology and Hepatology at Stanford University School of Medicine.

    Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.

    Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.

    After more than two decades of practice, Dr. Shah added training in liver transplant to expand his knowledge of liver disease and offer his patients a ?one-stop? resource for truly comprehensive care.

    Dr. Shah is a member of the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy, and American Association for the Study of Liver Disease.

    Among Dr. Shah?s current research interests is the development of an algorithm assessing the impact of gastrointestinal disease management on readmission rates.

    Dr. Shah brings a personalized approach to working with patients and to teaching the next generation of physician scientists the classic skills of careful listening and patient examination. Throughout his career, he has emphasized the fundamental importance of balancing scientific expertise with empathy and compassion.

    As a volunteer with the non-profit organization Health Volunteers Overseas, Dr. Shah travels around the world to train physicians about liver disease management and treatment. He is director of the HVO site in Bangalore, India.

  • Neha Shah

    Neha Shah

    Clinical Assistant Professor, Medicine - Immunology & Rheumatology

    Bio My clinical and research interests lie in Integrative Rheumatology, healing-oriented medicine that takes account of the whole patient, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies, including those outside the realm of allopathic medicine. Specifically, I am interested in exploring the impact of diet/nutrition/botanicals on inflammation as it pertains to rheumatic diseases such as gout, rheumatoid arthritis, lupus, psoriatic arthritis and other autoimmune conditions, as well as studying the impact of other lifestyle approaches such as mindful meditation, sleep, yoga, stress reduction, etc. on disease burden and quality of life of patients with rheumatic diseases.

  • Nigam H. Shah, MBBS, PhD

    Nigam H. Shah, MBBS, PhD

    Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science

    Current Research and Scholarly Interests We analyze multiple types of health data (EHR, Claims, Wearables, Weblogs, and Patient blogs), to answer clinical questions, generate insights, and build predictive models for the learning health system.

  • Nirav R. Shah, MD, MPH

    Nirav R. Shah, MD, MPH

    Adjunct Professor, Medicine - Primary Care and Population Health

    Bio Nirav R. Shah, MD, MPH, is Senior Scholar at Stanford University?s Clinical Excellence Research Center. He is a leader in patient safety and quality, innovation and digital health, and the strategies required to transition to lower-cost, patient-centered health care. Board-certified in Internal Medicine, Dr. Shah is a graduate of Harvard College and Yale School of Medicine, and is an elected member of the National Academy of Medicine. He serves as an independent director for STERIS plc, as trustee for The John A. Hartford Foundation, as Senior Fellow of the Institute for Healthcare Improvement (IHI), and as a member of the HHS Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030. Previously, he served as senior vice president and Chief Operating Officer for clinical operations for Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.

  • Sumit Shah

    Sumit Shah

    Clinical Assistant Professor, Medicine - Oncology

    Bio Dr. Sumit Shah specializes in the management of advanced urologic malignancies such as prostate, kidney, bladder, and testicular cancers. He also serves as an investigator on numerous clinical trials, with a focus on novel immunotherapy agents. His academic interests also include digital health technologies and novel healthcare delivery services, both in the domestic and international setting. Dr. Shah graduated with distinction in biomedical engineering from Duke University, received his medical doctorate from Stanford University, and Masters in Public Health from Harvard University. He completed his internal medicine residency at the University of California, San Francisco (UCSF) where he stayed on faculty for one year before returning to Stanford for his fellowship training in medical oncology, where he now serves on the faculty.

  • Shagufta Shaheen

    Shagufta Shaheen

    Clinical Assistant Professor, Medicine - Oncology

    Bio Dr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.

  • Mohammad Shahrokh Esfahani

    Mohammad Shahrokh Esfahani

    Instructor, Medicine - Oncology

    Bio My expertise is in developing machine learning tools for high dimensional data. In particular, I develop Bayesian models, where 'prior knowledge', from external sources or inherent to the data set in hand, can be converted into mathematical terms (i.e. prior probabilities). I have recently focused on analyzing genetic and epigenetic signals in cell-free DNA assays. Traditional (computational) methods in cancer genomics are limited when signal to noise ratio is ultra-low which is often the case in cfDNA analyses. Therefore, there is a growing need to develop novel and more powerful methods to overcome this limitation.

  • Husham Sharifi

    Husham Sharifi

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Bio Husham Sharifi is a Clinical Assistant Professor in Stanford's Division of Pulmonary, Allergy, and Critical Care Medicine. He sees patients in the Intensive Care Unit and in a specialty clinic for individuals with pulmonary manifestations after stem cell transplant, as well as patients with persistent symptoms after infection with COVID-19 (i.e., long COVID). His research interests include economics, policy, and data science in medicine. He holds a masters degree in Technology and Policy from MIT, a masters degree in Bioinformatics from Stanford, and an MD from Yale.

  • Rahul P Sharma, MBBS, FRACP

    Rahul P Sharma, MBBS, FRACP

    Clinical Associate Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Transcatheter valve therapies, CT valve imaging, AI and device innovation

  • Christopher Sharp, MD

    Christopher Sharp, MD

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Clinical Informatics
    Clinical Education
    Teaching Physical Examination
    Quality Improvement
    Preventive Medicine

  • Jonathan Shaw

    Jonathan Shaw

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Primary care, psycho-social determinants of health & care, maternal-child health

  • Meera Sheffrin

    Meera Sheffrin

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Geriatric education
    Stanford Geriatric Trauma Initiative
    Improving care for older adults with dementia

  • Kristen K. Sherman

    Kristen K. Sherman

    Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Bio Dr. Sherman is a primary care internist, taking care of adults of all ages with a focus on health promotion, disease prevention, and the management of chronic conditions. She enjoys long term relationships with her patients and she aims to be a partner in their health care, no matter what stage of life and health each patient is in. Dr. Sherman grew up in New Mexico, but has lived in the Bay Area for over 20 years--California is now definitely her home! She is the mother of 2 school-aged children and enjoys exercising, reading, and spending time with her family.

  • Judith Shizuru

    Judith Shizuru

    Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and of Pediatrics (Stem Cell Transplantation)

    Current Research and Scholarly Interests Transplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.

  • William Shomali

    William Shomali

    Clinical Assistant Professor, Medicine - Hematology

    Bio Dr. Shomali is a clinical assistant professor of Hematology at Stanford University School of Medicine. He is board certified in hematology & medical oncology.

    Dr. Shomali specializes in the treatment of blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes. He aims to provide compassionate, personalized, and evidence-based care to each patient.

    Dr. Shomali received his medical degree from the University of Jordan, followed by a postdoctoral fellowship at MD Anderson Cancer Center where he studied infections in cancer patients and the role of biomarkers in defining tumor fever. He completed his residency training in Internal Medicine at the Cleveland Clinic Foundation where he served as a Chief Medical Resident. He then joined Stanford University for his combined Hematology & Oncology fellowship training.

    Dr. Shomali?s research interests include the study of novel agents in myeloproliferative neoplasms and myelodysplastic syndromes. He developed investigator-initiated clinical trials for patients with eosinophilic neoplasms and advanced myelofibrosis. In addition, he co-authored several papers and book chapters discussing the care of patients with cancer. His work has been presented in national meetings and published in peer reviewed journals including Blood, American Journal of Hematology, British Journal of Hematology, Leukemia & Lymphoma, and Cancer.

    Among his honors, Dr. Shomali received the Cleveland Clinic Excellence in Teaching Award and was named to the Alpha Omega Alpha Medical Honor Society. He has received a Young Investigator Award from the Conquer Cancer Foundation, an NIH Institutional National Research Service Award, and a Stanford Cancer Institute Fellowship Award.

    Dr. Shomali is a member of the American Society of Hematology and the American Society of Clinical Oncology.

  • Stanford Shoor

    Stanford Shoor

    Clinical Professor, Medicine - Immunology & Rheumatology

    Current Research and Scholarly Interests Patient Centered Care in Rheumatic Disease
    Sarcoidosis

  • Aimee D. Shu

    Aimee D. Shu

    Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    Bio I am an endocrinologist with particular interests in reproductive and bone health.

    I enjoy treating patients with menstrual disorders, menopause, fractures, osteoporosis, parathyroid imbalance, and calcium imbalance.

    As a certified menopause practitioner (North American Menopause Society), I help women fine-tune their health at the mid-life transition. Some women transition through menopause with ease, while others experience challenging symptoms like hot flashes, slowed metabolism, and mood changes. This transition period provides a good opportunity to create a "game plan" for preserving future health. It also marks the beginning of natural bone loss, leaving one more susceptible to fragility fractures.

    I provide individualized treatment plans for bone health to men and women of all ages, including for those with specific challenges such as chronic steroid use. As a certified clinical densitometrist (International Society for Clinical Densitometry), I personally review all my patients' bone density scan images. Thus, please bring any non-Stanford bone density scan images to your appointment with me.

    Appointments with me are available on Stanford's main campus (300 Pastuer Drive) and at the Stanford Medicine Outpatient Center (450 Broadway, Redwood City).

  • Takudzwa Shumba

    Takudzwa Shumba

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Bio Dr. Takudzwa Shumba is a family medicine clinician-educator who delights in care of the entire family, with particular interests in preventative medicine, women's health, pediatrics and global health. She is pro-vaccine and evidence-based medicine, and committed to taking care of the whole patient.

    She was born and raised in Zimbabwe. Prior to beginning medical school at Stanford, she completed a Master's in Public Health, with a focus in global health. She has been involved in public health projects in Zimbabwe, Hong Kong and mainland China. She currently spends part of the year caring for patients and involved in medical education in Kenya. She completed her residency at Stanford Health Care - O'Connor Hospital Family Medicine in San Jose, prior to joining Stanford Family Medicine. LGBTQQI friendly.

    Clinical hours: M 12-5pm; T 8-am12pm; Th 8am-3pm; F 8am-1pm

  • Surbhi Sidana, MD

    Surbhi Sidana, MD

    Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    Bio Dr. Sidana is a hematologist/oncologist who is fellowship trained in advanced hematology with an emphasis on myeloma, amyloidosis, and dysproteinemia disorders. She is an Assistant Professor in the Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, at Stanford University School of Medicine. She leads the Myeloma Cellular Immunotherapy program at Stanford.

    Her areas of expertise include transplantation and novel cellular immunotherapies such as CAR-T-cell therapy for patients with multiple myeloma. For each patient, Dr. Sidana develops a personalized care plan designed to optimize outcomes and quality of life.

    Dr. Sidana conducts extensive research. Currently, she is conducting clinical trials of CAR-T therapy and bispecific T-cell engagers for treatment of patients with myeloma. She is studying patients? access to CAR-T cell therapy, the financial burden of the treatment, and its impact on patients? quality of life and cognitive function.

    Dr Sidana has received a grant from the Stanford Medicine Cancer Institute and NIH funding through the Stanford KL2 program to study adverse events of CAR-T therapy on patients and monitoring of patients undergoing CAR-T therapy using wearable devices.

    In the past, Dr. Sidana received Conquer Cancer Foundation Young Investigator Award from the American Society of Clinical Oncology for her research on the impact of clinical trial participation on patients with multiple myeloma and lymphoma. She has also received grants from the Amyloidosis Foundation and International Waldenstrom?s Macrogloulinemia Foundation to understand AL amyloidosis, a rare disease caused by buildup of an abnormal protein.

    Dr. Sidana has given presentations at regional and national conferences and her work has been published in high-impact journals.

    Dr. Sidana has been recognized for her work with many honors, including an Outstanding Hematology/Oncology Fellow award and Outstanding Research Fellow award from the Mayo Clinic.

    She is a member of the American Society of Hematology, American Society of Clinical Oncology, International Myeloma Society, International Society of Amyloidosis, and American Society of Transplantation & Cellular Therapy. Dr. Sidana is often an invited speaker at patient support groups as well as symposia and workshops for her peers.

  • Branimir I. Sikic, M. D.

    Branimir I. Sikic, M. D.

    Professor of Medicine (Oncology)

    Current Research and Scholarly Interests Research Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, CD47 as a target for activation of anticancer macrophases, Phase I trials of new drugs, gene expression profiling of cancers

  • Julia Fridman Simard

    Julia Fridman Simard

    Associate Professor of Epidemiology and Population Health and, by courtesy, of Medicine (Immunology & Rheumatology)

    Bio Julia Fridman Simard, ScD, is an Associate Professor of Epidemiology & Population Health, and, by courtesy, of Medicine in Immunology and Rheumatology at Stanford University School of Medicine.

    Dr. Simard earned her Masters and Doctorate of Science in Epidemiology degrees at the Harvard School of Public Health. During that time she trained with investigators at the Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy at Brigham and Women?s Hospital and the Cardiovascular Epidemiology Research Unit at Beth Israel Deaconess Medical Center. In 2008, Dr. Simard relocated to Sweden to begin a Postdoctoral Fellowship in Clinical Epidemiology at the Karolinska Institutet in Stockholm. She became an Assistant Professor in their Clinical Epidemiology Unit in 2011, and was later honored with a Karolinska Institutet Teaching Award. Leveraging the population-based registers of Sweden, Dr. Simard initiated a national register linkage study to examine the utility of registers in Systemic Lupus Erythematosus (SLE) research and develop an extensive data repository for future epidemiologic investigations.

    While maintaining a close collaboration with the Karolinska Institutet, she joined Stanford?s Epidemiology faculty in 2013. Dr. Simard studies outcomes such as malignancy, stroke, infection, and mortality, in patients with systemic autoimmune rheumatic diseases with a focus on systemic lupus erythematosus. Recently her primary research focus has shifted to the intersection between reproductive epidemiology and rheumatic disease fueled by a K01 career development award from the NIH (NIAMS) to study maternal and fetal outcomes in systemic lupus pregnancy. This led to collaborations with colleagues at Stanford, throughout the US, and abroad, and a series of projects focused on the diagnosis of preeclampsia and associated risks in pregnant women with systemic lupus. Dr. Simard was awarded a Peter Joseph Pappas Research Grant from the Preeclampsia Foundation for her lab's work examining preeclampsia risk in high-risk populations, and a McCormick Faculty Award from Stanford Medicine to take important steps towards disentangling preeclampsia from lupus nephritis. Dr. Simard is leading an international study of hydroxychloroquine in lupus pregnancy leveraging mixed methods in partnership with qualitative researchers, patients, clinicians, and epidemiologists in Sweden, Canada, and in the United States.

    In addition to these issues of misclassification in reproductive rheumatology questions, Dr. Simard's lab is also interested in how misclassification, missed opportunities, and misdiagnosis contribute to disparities in complex conditions such as systemic lupus. In addition to methodologic issues around misclassification and bias and the largely clinical epidemiology focus of her work, Dr. Simard's work examines social determinants of health and health disparities. Dr. Simard was recently awarded an R01 from NIH (NIAID) to study the role of cognitive and unconscious bias in clinical decision making for female-predominant diseases including lupus.

  • Sundeep Singh

    Sundeep Singh

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Bio After living and training throughout the country, I am excited to be part of the Stanford team. As a result of both my personal experiences and training, I am passionate about ensuring that patients receive appropriate diagnostic testing and treatment options in order to improve people's quality of life. In collaboration with my amazing colleagues, I am confident in the high quality and easily accessible care we are able to provide to patients across northern California.

    While my interest is most in inflammatory bowel disease, I am also interested in the interaction between mental health, incentives, and emerging therapies in gastroenterology.

  • Upinder Singh

    Upinder Singh

    Professor of Medicine (Infectious Diseases & Geographic Medicine) and of Microbiology and Immunology

    Current Research and Scholarly Interests Our lab elucidates the molecular basis of pathogenesis of the protozoan parasite Entamoeba histolytica. We use genetic and genomic approaches to identify novel virulence determinants and to characterize the global epidemiology of the parasite.

  • Sidhartha Sinha

    Sidhartha Sinha

    Assistant Professor of Medicine (Gastroenterology and Hepatology)

    Current Research and Scholarly Interests There are two primary and overlapping emphases of my research, both of which are driven and united by needs-based innovation and translational potential:

    (1) Understanding the microenvironment of the inflamed versus normal gut in order to identify better therapeutic targets for people with immune-¬mediated GI disorders. Here, our investigations include understanding the influence and interactions of pharmacologic and dietary interventions on gut microbiome/metabolomic changes and the host immune response. In the context of providing patients with new understanding and solutions for their disease, I have led and advised on the design of both pilot and large clinical trials (including new FDA approved therapies) for anti-inflammatory therapies;

    (2) Applying novel approaches and technologies (including natural language processing, computer vision, and reinforcement learning) to identify and address unmet clinical needs. In this area we have ongoing and published efforts in my lab to validate and develop solutions to pressing clinical needs. We have developed/led new drug delivery technologies with a multidisciplinary team that have shown strong potential in ongoing human IBD clinical trials. My lab has utilized both supervised and unsupervised approaches to analyze social media discourse and unstructured data sets for identifying patient needs that are rarely addressed in clinical settings. We have gained insights into patient perceptions around preventative health interventions, such as health screening and diet, including the dearth of evidence-based dietary recommendations to treat IBD (despite strong patient desire for solutions in this domain).

  • Kelley M. Skeff, MD, PhD

    Kelley M. Skeff, MD, PhD

    George DeForest Barnett Professor of Medicine

    Current Research and Scholarly Interests Development and evaluation of improved teaching methods; assessment of teacher's attitudes toward their teaching role; study of clinical teaching; evaluation of alternative methods of learning in clinical clerkships (e.g. computer assisted instruction, video tape review, etc.).

  • Peter Michael Sklarin

    Peter Michael Sklarin

    Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Bio Dr. Sklarin practices endocrinology at Menlo Medical Clinic. He is a graduate of Harvard College, where he majored in biology. He attended medical school at the University of California, San Francisco, completed his internal medicine residency at Brigham and Women?s Hospital in Boston, and completed his endocrinology fellowship at the University of California, San Francisco.

    Dr. Sklarin is board certified in Endocrinology, Diabetes, and Metabolism and treats patients with a wide variety of endocrine disorders. He has special expertise in thyroid ultrasound and ultrasound guided fine-needle aspiration and directs the Menlo Clinic bone density center.

    In his free time Dr. Sklarin enjoys spending time with his family, playing tennis, running, biking, swimming, and doing triathlons.

  • Grant M. Smith, MD

    Grant M. Smith, MD

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Bio Dr. Grant Smith is originally from Knoxville, TN. He graduated with a bachelor of science in psychology from Duke University, where he first developed an interest in palliative care. He received his medical degree from Harvard Medical School. He completed residency in internal medicine at the University of California, San Francisco with a focus in primary care, followed by a chief resident year at the Zuckerberg San Francisco General Hospital. He subsequently completed his palliative care fellowship at the University of California, San Francisco. Outside of work, Dr. Smith lives in San Francisco, and he enjoys running in Golden Gate park, cooking, and visiting the many great restaurants in the area. Dr. Smith is excited to be part of the Stanford faculty, where he provides direct patient care while pursuing his academic and educational interests improving patient-centered care across settings, increasing access to palliative care, and promoting clinician well-being.

  • Irene Sonu

    Irene Sonu

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    Bio I am passionate about gut health and strive to provide the best care to my patients. I specialize in complex motility disorders of the gastrointestinal tract. My areas of clinical expertise include achalasia, dysphagia, eosinophilic esophagitis, gastroesophageal reflux disease, gastroparesis, functional dyspepsia, irritable bowel syndrome, and pelvic floor dysfunction. I also see patients in need of fecal microbiota transplant for recurrent C. difficile infection.

  • Edda Spiekerkoetter

    Edda Spiekerkoetter

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly Interests Pulmonary Arterial Hypertension
    Pulmonary Vascular Remodeling
    Modulation of BMP signaling
    BMP signaling in health and disease in the right ventricle of the heart
    "BMP signature" in blood as a biomarker
    BMP signaling in neonatal chronic lung disease

  • Joshua M. Spin

    Joshua M. Spin

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Dr. Spin began his research career studying the structural biology of low density lipoprotein, and has been augmenting his skills with intensive training in molecular biology techniques, particularly those involving high-throughput genetic expression profiling. He is especially interested in vascular smooth muscle cells, and the role of smooth muscle differentiation and phenotypic switching in development and vascular disease. His latest work has focused on the biology of aortic aneurysms.

  • Michael Spinner

    Michael Spinner

    Instructor, Medicine - Oncology

    Bio Dr. Michael Spinner received his undergraduate degree in music (classical guitar performance) from Emory University, received his medical degree from Vanderbilt University, and completed his internal medicine residency and hematology/oncology fellowship at Stanford University Medical Center. As a medical student, Michael participated in the National Institutes of Health Medical Research Scholars Program, working with Dr. Steven Holland on characterizing a novel immunodeficiency and bone marrow failure disorder resulting from germline GATA2 mutations (GATA2 deficiency). This work led to a new clinical protocol to better understand the natural history of GATA2 deficiency, a highly cited publication in Blood, and an NIH Merit Award for outstanding clinical research. At Stanford under the mentorship of Drs. Ranjana Advani, Robert Lowsky, and Peter Greenberg, Michael's research has focused on therapeutic clinical trials for patients with blood cancers, including studies of novel immunotherapies, cellular therapies, and precision medicine approaches using genomics and ex vivo drug sensitivity screening to inform personalized therapy. Under Dr. Advani?s mentorship, Michael has developed particular expertise in the management of Hodgkin and non-Hodgkin lymphomas and the use of novel immunotherapies and biologically-focused therapies to treat these disorders. Michael currently sees patients with lymphoma in the Stanford Cancer Center and is actively involved in multiple clinical trials and translational research collaborations. Outside of medicine, Michael is an avid classical guitarist with a passion for classical music and jazz.

  • Sandy Srinivas

    Sandy Srinivas

    Professor of Medicine (Oncology) and, by courtesy, of Urology

    Current Research and Scholarly Interests Clinical interests: general oncology, genito-urinary malignancy Research interests: conducting clinical trials in advanced prostate cancer, bladder cancer and renal cell carcinoma

  • Malathi Srinivasan

    Malathi Srinivasan

    Clinical Professor, Medicine - Primary Care and Population Health

    Bio Dr. Srinivasan is a Clinical Professor of Medicine at Stanford University, Associate Director at the Stanford Center for Asian Healthcare Research and Education (Stanford CARE), Fellow at the Stanford Center for Innovation in Global Health (CIGH), board member at the Stanford Clinical Teaching Seminar Series, and member of the Stanford Teaching and Mentoring Academy (TMA). She is co-Director of the One Health Teaching Scholars Faculty Development Program, an international program focusing on faculty development for health professions education around the world. She is a contributor to CBS-KPIX ?Medical Mondays?. Dr. Srinivasan brings her skills as an educator, physician, health services researcher, and entrepreneur to considering how scalable technologies can improve health care. Her work in Virtual Health/telemedicine and new patient engagement models has been published in the NEJM Catalyst ? a leading healthcare innovation journal.

    Previously, Dr. Srinivasan was a Master Clinical Educator and Professor of Clinical Medicine at the University of California, Davis School of Medicine. She was the Senior Associate Editor and Editorial Fellowship Director for the Journal of General Internal Medicine, and was the Kimitaka Kaga Visiting Professor at the University of Tokyo at the International Research Center for Medical Education. At UC Davis, Dr. Srinivasan was the Director of Practice Based Learning and Improvement and Medical Director of the Clinical Performance Examination for a decade. She is former President of the California-Hawaii Society of General Internal Medicine, and ex-officio National Council Member for SGIM. She was a RWJ Foundation Generalist Physician Faculty Scholar and US Health and Human Service Public Policy Fellow. Dr. Srinivasan has been awarded the California SGIM Educator of the Year Award, and was recognized by her university with the Dean?s Award for Excellence in Education. Her research has focused on improving physician competency around clinical decision-making, through Virtual Health, technology-aided education and reflective practice.

  • Randall Stafford

    Randall Stafford

    Professor of Medicine (Stanford Center for Research in Disease Prevention)

    Current Research and Scholarly Interests As Director of the SPRC Program on Prevention Outcomes and Practices, my work focuses on cardiovascular disease treatment and prevention, the adoption of new technology and practices, and patterns of physician practice, particularly medication prescribing. Specific interests include measuring and improving the quality of outpatient care, disparities in health care by race, gender, age and socioeconomic status, and interventions to improve prevention outcomes.

  • Marcia L. Stefanick, Ph.D.

    Marcia L. Stefanick, Ph.D.

    Professor (Research) of Medicine (Stanford Prevention Research Center), of Obstetrics and Gynecology and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly Interests Marcia L. Stefanick, Ph.D is a Professor of Medicine Professor of Obstetrics and Gynecology, and by courtesy, Professor of Epidemiology and Population Health at Stanford University School of Medicine. Dr. Stefanick?s research focuses on chronic disease prevention (particularly, heart disease, breast cancer, osteoporosis, and dementia) in both women and men. She is currently the Principal Investigator the Women?s Health Initiative (WHI) Extension Study, having been the PI of the Stanford Clinical Center of the landmark WHI Clinical Trials and Observational Study since 1994 and Chair of the WHI Steering and Executive Committees from 1998-2011, as well as PI of the WHI Strong and Healthy (WHISH) Trial which is testing the hypothesis that a DHHS-based physical activity intervention, being delivered to a multi-ethnic cohort of about 24,000 WHI participants across the U.S., aged 68-99 when the trial started in 2015, will reduce major cardiovascular events over 8 years, compared to an equal number of ?usual activity? controls. Dr. Stefanick is also PI of the Osteoporotic Study of Men (MrOS) which is continuing to conduct clinical assessments of bone and body composition in survivors of an original cohort of nearly 6000 men aged 65 and over in 2001. As founding Director of the Stanford Women?s Health and Sex Differences in Medicine (WHSDM, ?wisdom?) Center, she plays a major role in promoting research and teaching on Sex and Gender in Human Physiology and Disease, Women?s Health and Queer Health and Medicine. Dr. Stefanick also plays major leadership roles at the Stanford School of Medicine, including as co-leader of the Population Sciences Program of the Stanford Cancer Institute, Stanford?s NCI-funded comprehensive cancer center.

    Dr. Stefanick obtained her B.A. in biology from the University of Pennsylvania, Philadelphia, PA (1974), then pursued her interest in hormone and sex difference research at the Oregon Regional Primate Research Center, after which she obtained her PhD in Physiology at Stanford University, focusing on reproductive physiology and neuroendocrinology, with exercise physiology as a secondary focus. Her commitment to human research led to a post-doctoral fellowship in Cardiovascular Disease Prevention at the Stanford Prevention Research Center, which has been her academic home for nearly 40 years.

  • Simon H. Stertzer, MD, FACC,FAHA,FACP

    Simon H. Stertzer, MD, FACC,FAHA,FACP

    Professor of Medicine (Cardiovascular) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests Coronary Angioplasty; Intramyocardial Stem cell delivery

  • David A. Stevens

    David A. Stevens

    Professor of Medicine, Emeritus

    Current Research and Scholarly Interests Immunology and chemotherapy of human fungal diseases, particularly coccidioidomycosis (Valley Fever) in California and aspergillosis, and the parasitic disease, trypanosomiasis.

  • Frank E. Stockdale

    Frank E. Stockdale

    Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus

    Current Research and Scholarly Interests Laboratory and clinical research in breast cancer ; Normal and abornal differentiation and growth

  • Sarah Streett

    Sarah Streett

    Clinical Professor, Medicine - Gastroenterology & Hepatology

    Bio Dr. Sarah Streett is a Clinical Professor of Medicine, the Director of Inflammatory Bowel Disease Education at Stanford, and she is passionate about taking care of people with IBD. She is a national expert in treating complex IBD and initiated a multi-disciplinary approach to care with colorectal surgery, pediatrics, and nutrition. In 2018 she received the Champion of Hope Award from the Crohn?s and Colitis Foundation and serves on their National Scientific Advisory Committee. Her interests focus on fertility and pregnancy in people with IBD, developing precision approaches to IBD therapy, and the role that the microbiome and diet play in its pathogenesis. She is a primary investigator of the Stanford IBD Registry and has research projects focused on optimizing clinical outcomes in IBD, the role of the microbiota and diet in IBD and pregnancy, and applying new technologies to individualizing therapy for IBD. She is also the primary investigator on multiple industry-sponsored IBD trials.

    Teaching is a top priority for Dr. Streett who feels that mentoring fellows in the development of their careers is a privilege. She has held many national leadership roles in the American Gastroenterological Association, where she has been Chair of the Practice Management and Economics Committee, and currently serves on the Government Affairs Committee. She also an appointed member of the Gastrointestinal Drug Advisory Committee at the FDA. She has represented the interests of gastroenterologists and their patients on Capitol Hill numerous times. Dr. Streett believes strongly in a collaborative approach to give patients personalized care based on the latest therapies for the treatment of IBD and is committed to mentoring the next generation of experts in the field.

  • Samuel Strober

    Samuel Strober

    Professor of Medicine (Immunology and Rheumatology)

    Current Research and Scholarly Interests Mechanisms of immune tolerance; regulatory processes in autoimmunity and transplantation and extrathymic T cell maturation.

  • Eric Strong

    Eric Strong

    Clinical Associate Professor, Medicine

    Current Research and Scholarly Interests Physical diagnosis, ECG interpretation, use of social media in medical education

Stanford Medicine Resources: